Investing in longer lifespans

Pharma has been a real boon to the Irish economy over the last two decades. Leman Solicitors is banking on medical devices replicating this success, helping to guide investment strategies in the burgeoning sector.

9th June, 2019
Mark Roberts, partner at Leman Solicitors

The introduction of digital technologies into the medical device sector is likely to prove transformative: personalised healthcare, at least in pharmaceutical terms, is not quite here yet, but medical devices are already personalising both diagnosis and drug delivery.

This is a real boon for patients, medical staff and, in economic terms, the country as a whole, according to Mark Roberts, partner at Leman Solicitors.

“We’re seeing a lot of start-ups and research. Diabetes is a...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Supporting the multi-billion euro offshore wind supply chain

AI is a game changer

The next normal

Futureproofing your pension savings during a pandemic